SB 2625
Campbell’s bill on providing abortion-inducing drugs
Died in committee
Verdict: No flags
Initial review · graded Oct 19, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
Caption
relating to the provision of an abortion-inducing drug.
Caption from analyzed text · version I.
Summary
A physician physically in Texas, with an in-person exam.
The bill tightens Texas rules on who may hand out abortion-inducing drugs, requiring that the provider be a physician who is physically in Texas and examines the pregnant woman in person when the drug is given. It also requires the physician to schedule an in-person follow-up visit within 14 days to confirm the pregnancy has ended and check for continued bleeding. Out-of-state doctors who now fall under consultation exemptions from Texas licensing rules would lose those exemptions for any consultation tied to abortion-inducing drugs.
Labels
Labels: NEVER GOT A HEARING. Filed Mar 13, 2025 and referred to the Senate State Affairs committee. No public hearing. The bill died.
Receipt
The receipt
89R-SB2625 · 2025-03-13
SOLD BY
ITEM
relating to the provision of an abortion-inducing drug.
WHAT IT DOES
A physician physically in Texas, with an in-person exam.
The bill tightens Texas rules on who may hand out abortion-inducing drugs, requiring that the provider be a physician who is physically in Texas and examines the pregnant woman in person when the drug is given. It also requires the physician to schedule an in-person follow-up visit within 14 days to confirm the pregnancy has ended and check for continued bleeding. Out-of-state doctors who now fall under consultation exemptions from Texas licensing rules would lose those exemptions for any consultation tied to abortion-inducing drugs.
CHARGES
[ ] NONE FOUND
TOTAL
No fiscal note in the loaded record.
HISTORY
- Received by the Secretary of the Senate
- Filed
- Read first time
- Referred to State Affairs
FILED UNDER
Beats not yet reviewed.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
CAMPAIGN PAID FOR BY
Donors
Donors report through Friends of Donna Campbell.
Not tied to this bill.
Sources
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Oct 27, 2024 to Jun 30, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
MoneyMissing data does not establish zero giving. Display amounts are rounded.
Votes
No floor vote loaded for this bill.
Fiscal
No fiscal note in the loaded record.
How this was graded
Analysis of text version I by claude-opus-5-5, Oct 19, 2026, against the published rubric.
Sources
Texas Senate · Filed Mar 13, 2025
04/03/2025 S Referred to State Affairs
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.
Senate committee · State Affairs · Final status: Died in committee
Companion
HB 4593 by Troxclair (similar)
Subjects
Abortion
MEDICINE & PRESCRIPTION DRUGS
PREGNANCY & CHILDBIRTH
Text
The text as introduced · 441 words
By: Campbell, Paxton S.B. No. 2625 A BILL TO BE ENTITLED AN ACT relating to the provision of an abortion-inducing drug. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 171.063, Health and Safety Code, is amended by amending Subsections (a) to read as follows: (a) A person may not knowingly provide an abortion-inducing drug to a pregnant woman for the purpose of inducing an abortion in the pregnant woman or enabling another person to induce an abortion in the pregnant woman unless: (1) the person who provides the abortion-inducing drug is a physician; [ and ] (2) the person is physically present in this state and personally examines the pregnant woman in person at the time the person provides the abortion-inducing medication to the pregnant woman; and (3) the provision of the abortion-inducing drug satisfies the protocol authorized by this subchapter. (e) A physician who provides the abortion-inducing drug, or the physician's agent, must schedule a n in person follow-up visit for the woman to occur not later than the 14th day after the earliest date on which the abortion-inducing drug is administered or used or the abortion is performed or induced. At the follow-up visit, the physician must: (1) confirm that the woman's pregnancy is completely terminated; and (2) assess any continued blood loss. SECTION 2. Section 151.056, Occupations Code, is amended by amending Subsection (b) and adding Subsection (b-1) to read as follows: (b) Except as provided by Subsection (b-1), this [ This ] section does not apply to the act of: (1) a medical specialist located in another jurisdiction who provides only episodic consultation services on request to a physician licensed in this state who practices in the same medical specialty; (2) a physician located in another jurisdiction who is providing consultation services to a medical school as defined by Section.61.501, Education Code; (3) a physician located in another jurisdiction who is providing consultation services to an institution subject to: (A) Subchapter C, Chapter 73, Education Code; or (B) Subchapter K, Chapter 74, Education Code; or (4) a physician located in another jurisdiction of a state having borders contiguous with the borders of this state who is the treating physician of a patient and orders home health or hospice services for a resident of this state to be delivered by a home and community support services agency licensed in this state. (b-1) This section applies to any consultation service described in Subsection (b) if the service relates to the provision of an abortion-inducing drug, as defined by Section 171.061, Health and Safety Code. SECTION 3. This Act takes effect September 1, 2025.
